Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1

被引：0
|
作者：
不详
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 2014年 / 161卷 / 07期
关键词：
D O I：
10.7326/P14-9035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：I / 22
页数：1
相关论文
共 50 条
  • [41] Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1
    Gupta, Kavita M.
    Pearce, Serena M.
    Poursaid, Azadeh E.
    Aliyar, Hyder A.
    Tresco, Patrick A.
    Mitchnik, Mark A.
    Kiser, Patrick F.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (10) : 4228 - 4239
  • [42] Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients
    Hachiya, Atsuko
    Shimane, Kazuki
    Sarafianos, Stefan G.
    Kodama, Eiichi N.
    Sakagami, Yasuko
    Negishi, Fujie
    Koizumi, Hirokazu
    Gatanaga, Hiroyuki
    Matsuoka, Masao
    Takiguchi, Masafumi
    Oka, Shinichi
    ANTIVIRAL RESEARCH, 2009, 82 (03) : 115 - 121
  • [43] Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide
    Margot, Nicolas A.
    Wong, Pamela
    Kulkarni, Rima
    White, Kirsten
    Porter, Danielle
    Abram, Michael E.
    Callebaut, Christian
    Miller, Michael D.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (06): : 920 - 927
  • [44] Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects
    Kuritzkes, Daniel R.
    Lalama, Christina M.
    Ribaudo, Heather J.
    Marcial, Michelle
    Meyer, William A., III
    Shikuma, Cecilia
    Johnson, Victoria A.
    Fiscus, Susan A.
    D'Aquila, Richard T.
    Schackman, Bruce R.
    Acosta, Edward P.
    Gulick, Roy M.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (06): : 867 - 870
  • [45] Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1
    McCormick, Adele L.
    Parry, Chris M.
    Crombe, Anne
    Goodall, Ruth L.
    Gupta, Ravindra K.
    Kaleebu, Pontiano
    Kityo, Cissy
    Chirara, Michael
    Towers, Greg J.
    Pillay, Deenan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1806 - 1809
  • [46] Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations
    Wong, Alexander
    Goldstein, Deborah
    Mallolas, Josep
    DeJesus, Edwin
    Johnson, Margaret
    Molina, Jean-Michel
    Pozniak, Anton
    Rodgers, Anthony
    Teal, Valerie
    Hepler, Deborah
    Kumar, Sushma
    Sklar, Peter
    Hanna, George J.
    Hwang, Carey
    Badshah, Cyrus
    Teppler, Hedy
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 (04) : E47 - E49
  • [47] Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens
    Sarmati, Loredana
    Parisi, Saverio Giuseppe
    Nicastri, Emanuele
    d'Ettorre, Gabriella
    Andreoni, Carolina
    Dori, Luca
    Gatti, Francesca
    Montano, Marco
    Buonomini, Anna Rita
    Boldrin, Caterina
    Palu, Giorgio
    Vullo, Vincenzo
    Andreoni, Massimo
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (07) : 880 - 886
  • [48] Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans
    Nanzigu, S.
    Eriksen, J.
    Makumbi, F.
    Lanke, S.
    Mahindi, M.
    Kiguba, R.
    Beck, O.
    Ma, Q.
    Morse, G. D.
    Gustafsson, L. L.
    Waako, P.
    HIV MEDICINE, 2012, 13 (04) : 193 - 201
  • [49] Treatment of primary HIV-1 infection with nonnucleoside reverse transcriptase inhibitor-based therapy is effective and well tolerated
    Portsmouth, S
    Imami, N
    Pires, A
    Stebbing, J
    Hand, J
    Nelson, M
    Gotch, F
    Gazzard, BG
    HIV MEDICINE, 2004, 5 (01) : 26 - 29
  • [50] MECHANISM OF INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY NONNUCLEOSIDE INHIBITORS
    ESNOUF, R
    REN, JS
    ROSS, C
    JONES, Y
    STAMMERS, D
    STUART, D
    NATURE STRUCTURAL BIOLOGY, 1995, 2 (04): : 303 - 308
12345